Executive Summary / Key Takeaways

• Flexible Solutions International is strategically pivoting towards higher-margin food-grade and potentially pharmaceutical markets while mitigating geopolitical tariff risks through international expansion in Panama.
• Recent financial performance in Q1 2025 was impacted by temporary customer inventory reductions and project-related expenses, but management anticipates a return to growth in the second half of 2025, driven by new initiatives.
• The company's core differentiated thermal polyaspartate (TPA) technology provides a foundation for its specialty chemical business and is being leveraged for new opportunities in food and nutrition, offering quantifiable benefits in various applications.
• A significant new food-grade contract, requiring approximately $4 million in CapEx, is a critical near-term focus with the potential to add up to $30 million in annual revenue by early 2026, contingent on successful execution and scaling.
• Debt reduction efforts are set to free up over $2 million in annual cash flow by 2026, providing financial flexibility to support strategic investments and potentially enhance shareholder returns through dividends.

A Specialty Chemical Innovator's Strategic Pivot

Flexible Solutions International, Inc. traces its roots back to 1998, initially focused on developing chemicals to combat water evaporation with products like HEATSAVR and WATERSAVR. Over time, the company expanded its expertise into biodegradable thermal polyaspartate (TPA) biopolymers, finding applications across diverse industries from oil and gas to agriculture and cleaning products. This evolution laid the groundwork for FSI's current strategic direction: leveraging its core chemical knowledge and manufacturing capabilities to pursue higher-value, less cyclical markets while simultaneously addressing external challenges like tariffs.

The company operates primarily through two segments: Energy and Water Conservation Products (EWCP) and Biodegradable Polymers, Chemicals, and Agriculture (BPCA), often referred to as the NanoChem division (NCS). The BPCA segment, representing approximately 70% of FSI's revenue, has been the engine for diversification, incorporating nitrogen conservation products for agriculture and, more recently, expanding significantly into food-grade and nutritional materials. This strategic shift is central to FSI's narrative, aiming to build upon its established foundation to capture new growth opportunities.

The Power of Polyaspartates: FSI's Technological Edge

At the heart of FSI's BPCA segment lies its thermal polyaspartate (TPA) technology. These biodegradable biopolymers, derived from L-aspartic acid, offer distinct functional benefits across various applications. In agriculture, TPAs enhance fertilizer uptake by slowing crystal growth, allowing nutrients to remain available longer for plants and improving crop yields. The TPA division's nitrogen conservation products, SUN 27 and N Savr 30, specifically target nitrogen loss from soil, a critical factor in fertilizer efficiency.

In industrial settings, TPAs are formulated to prevent corrosion and scaling in water piping within the petroleum, chemical, utility, and mining industries, extending equipment life and reducing maintenance costs. For consumers, TPAs serve as biodegradable additives in detergents and personal care products, increasing biodegradability and preventing dirt redeposition. While precise, directly comparable quantitative performance metrics across all competitor products are challenging to ascertain, FSI's TPA technology is positioned to offer specific advantages, such as enhancing fertilizer availability or reducing scale formation, differentiating its offerings in niche applications. The company's expansion into food-grade products leverages its ability to produce custom, confidential ingredients using specialized equipment and clean room environments, a capability developed over the last three years and now a key technological differentiator for entering new, high-specification markets.

Navigating Tariffs and Expanding Horizons: Strategic Initiatives

Geopolitical factors, particularly tariffs on raw materials imported from China (ranging from 30% to 58.5%), have significantly impacted FSI's cost of goods, cash flow, and profits since 2019. While the company has applied for export rebates to recover tariffs paid on materials used for international sales, this process has proven difficult and time-consuming, with over $1 million due and growing quarterly. In response, FSI is undertaking a major strategic initiative: establishing a duplicate agriculture and polymer factory in Panama.

This new facility, expected to begin first production in Q3 2025, is designed to produce nearly all products for international customers using raw materials sourced without U.S. tariffs. Funded entirely by existing cash flow and retained earnings, the Panama plant is located near a port, promising reduced shipping times and costs. This move not only mitigates tariff exposure for international sales but also strategically frees up valuable space at the Illinois plant, allowing for optimized and expanded food-grade production to serve the U.S. market.

The push into the food and nutrition supplement manufacturing markets represents another critical strategic pillar. Following FDA and SQF certifications and the commercialization of an in-house developed wine stability aid, FSI announced a significant new food-grade contract in January 2025. This contract, focused on a product new to FSI's manufacturing, requires approximately $4 million in CapEx for specialized equipment and a new clean room, funded by cash on hand and existing lines of credit. Management views this as a critical goal with the potential to generate up to $30 million in annual revenue by the start of 2026, contingent on successful installation, testing, and scaling of production. The company believes its established food-grade and SQF operations, including its high-quality clean room environments, provide a competitive advantage in securing this business.

Looking further ahead, FSI has acquired a production line for injectable drugs, viewing the drug compounding industry as a logical long-term progression. While this opportunity requires significant capital or a partner to fully de-risk, the company believes its transferable skills in operating clean room environments position it well for potential entry into highly profitable drug categories like GLP-1s, albeit cautiously, seeking secured sales and partners before significant further investment.

Financial Performance and Outlook: Overcoming Headwinds

FSI's recent financial performance reflects a period of transition and temporary headwinds. For the three months ended March 31, 2025, sales decreased by 19% to $7.47 million compared to $9.22 million in the same period of 2024. This decline was primarily attributed to decreased customer orders in both the EWCP and TPA segments, including inventory reductions by two large customers. Gross profit also saw a significant decrease, falling to $1.95 million in Q1 2025 from $2.82 million in Q1 2024, impacted by lower sales volume and increased tariffs.

Operating expenses saw mixed movements, with decreases in wages and administrative salaries due to non-recurring stock options from the prior year, but increases in professional fees (tax/audit), utilities (new real estate), and advertising. The company reported a net loss of $278,000 ($0.02 per share) in Q1 2025, compared to a net income of $457,000 ($0.04 per share) in Q1 2024. This loss was partly influenced by costs associated with preparing for the new food-grade contract and the Panama factory, which are being expensed as they occur. Operating cash flow for Q1 2025 was $480,000, down from $1.38 million in Q1 2024.

Despite the Q1 weakness, management expresses confidence in a return to growth. They expect the temporary inventory reductions and reduced ENP sales to end in Q2 2025, leading to better results in the second quarter compared to the first. Growth is anticipated to be concentrated in the second half of 2025, driven by the new food-grade contract (with potential revenue starting in Q4) and continued growth in the ENP division and sales to the Florida LLC investment (which FSI sold a majority stake in for $6M but remains an exclusive supplier). Expenses related to the Panama factory and food product expansion are expected to continue impacting profits in Q2 and Q3 2025, after which profits are projected to revert to past levels and increase as new revenue streams scale.

FSI maintains a solid liquidity position. As of March 31, 2025, working capital stood at $22.80 million, slightly up from $22.71 million at December 31, 2024. Cash and term deposits totaled $11.03 million. The company has access to lines of credit and is funding its strategic CapEx initiatives (Panama factory, food-grade expansion) from existing cash flow and retained earnings without needing equity financing. Furthermore, significant debt reduction is underway, with the loan for the ENP division being paid in full in June 2025 and a 3-year equipment note fully paid in December 2025. These payments are expected to free up over $2 million in annual cash flow, providing additional financial flexibility for future investments or shareholder returns, such as the recently declared ten-cent special dividend payable in May 2025.

Competitive Landscape and Positioning

FSI operates within the broader specialty chemicals market, competing with much larger, diversified players like Dow Inc. (DOW), BASF SE (BASF), Ecolab Inc. (ECL), and Corteva Agriscience (CTVA). These giants possess significant scale, extensive R&D budgets, and global distribution networks. FSI's strategy is not to compete head-to-head across the board but to leverage its specialized TPA technology and manufacturing flexibility to carve out profitable niches.

In the TPA market (excluding food), FSI competes with expert companies primarily located in China. While these competitors may offer products at moderate margins, FSI aims to differentiate through product performance and, increasingly, through strategic operational advantages like the Panama factory, which will help it compete more effectively on price and delivery times for international customers by avoiding U.S. tariffs. FSI's gross profit margin (TTM 33.91%) is competitive, falling within the range of its larger peers (DOW 11%, ECL 43%, CTVA 44%), suggesting its specialized products can command reasonable pricing despite its smaller scale.

The expansion into food-grade manufacturing positions FSI in a market where domestic production is often preferred, offering some insulation from geopolitical trade issues. The company believes its willingness to invest in specialized equipment and its demonstrated high-quality food-grade and SQF operations provide a competitive edge in securing new contracts in this vertical, where it may face fewer direct competitors with the same specific capabilities in North America. While larger companies like Ecolab and Corteva have strong positions in water treatment and agriculture, FSI's focus on niche applications of TPAs and nitrogen conservation products allows it to offer specific, quantifiable benefits that resonate with customers seeking enhanced performance or environmental advantages.

Conclusion

Flexible Solutions International is navigating a period of strategic transformation, marked by investments in new growth areas and operational adjustments to mitigate external risks. While recent financial results reflect temporary headwinds from customer inventory cycles and project-related expenses, the underlying strategic initiatives in food-grade manufacturing and international expansion via the Panama factory hold significant potential to drive future revenue and profit growth.

The company's core TPA technology and growing expertise in high-specification manufacturing environments provide a foundation for this pivot. Successful execution of the new food-grade contract, with its substantial revenue potential, is a key factor to watch in the coming quarters. Coupled with ongoing debt reduction freeing up cash flow and a strategic response to tariff challenges, FSI appears to be positioning itself for a stronger competitive standing and improved financial performance beyond the current transition phase. Investors should monitor the progress of these strategic projects and the company's ability to translate its technological capabilities into sustained growth in its targeted niche markets.
```